Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer

The enzyme phosphatidylinositide-3-kinase (PI3K) regulates cellular proliferation and apoptosis. Somatic mutations in the PIK3CA gene can accelerate these processes and significantly contribute to the development and progression of breast cancer. This study aimed to ascertain the PIK3CA gene mut...

Full description

Saved in:
Bibliographic Details
Main Authors: Gizem Teoman, Zeynep Turkmen Usta, Zeynep Sagnak Yilmaz, Sevdegul Aydin Mungan, Ismail Saygin
Format: Article
Language:English
Published: Termedia Publishing House 2024-12-01
Series:Polish Journal of Pathology
Subjects:
Online Access:https://www.termedia.pl/Association-of-PIK3CA-somatic-mutations-with-clinicopathological-parameters-in-breast-cancer,55,55290,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584722027380736
author Gizem Teoman
Zeynep Turkmen Usta
Zeynep Sagnak Yilmaz
Sevdegul Aydin Mungan
Ismail Saygin
author_facet Gizem Teoman
Zeynep Turkmen Usta
Zeynep Sagnak Yilmaz
Sevdegul Aydin Mungan
Ismail Saygin
author_sort Gizem Teoman
collection DOAJ
description The enzyme phosphatidylinositide-3-kinase (PI3K) regulates cellular proliferation and apoptosis. Somatic mutations in the PIK3CA gene can accelerate these processes and significantly contribute to the development and progression of breast cancer. This study aimed to ascertain the PIK3CA gene mutations in breast cancer patients and investigate their correlation with certain clinicopathological characteristics. We conducted a mutational investigation of the PIK3CA gene using next-generation sequencing (NGS) in a sample of 100 cases of primary breast cancer. We investigated the associations between PIK3CA mutations and clinicopathological characteristics. Our analysis revealed a mutation rate of 45% in the PIK3CA gene. The mutation frequencies for the three hotspot sites were 33.3% for E545K in exon 10, 26.7% for H1047R in exon 20, and 6.7% for E542K in exon 10. Of the 45 individuals with tumors carrying the PIK3CA mutation, 41 (91.2%) had only one mutation, while 4 (8.8%) had two. Pathogenic PIK3CA mutations were significantly correlated with tumor size ( p = 0.015) and tumor location ( p = 0.017). Our study results demonstrated a significant association between tumor size, location, and presence of the PIK3CA mutation. We must validate these data in larger sample sizes.
format Article
id doaj-art-542d625147c549daabf86546edd5dce2
institution Kabale University
issn 1233-9687
2084-9869
language English
publishDate 2024-12-01
publisher Termedia Publishing House
record_format Article
series Polish Journal of Pathology
spelling doaj-art-542d625147c549daabf86546edd5dce22025-01-27T11:36:31ZengTermedia Publishing HousePolish Journal of Pathology1233-96872084-98692024-12-0175426827310.5114/pjp.2024.14570255290Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancerGizem TeomanZeynep Turkmen UstaZeynep Sagnak YilmazSevdegul Aydin MunganIsmail SayginThe enzyme phosphatidylinositide-3-kinase (PI3K) regulates cellular proliferation and apoptosis. Somatic mutations in the PIK3CA gene can accelerate these processes and significantly contribute to the development and progression of breast cancer. This study aimed to ascertain the PIK3CA gene mutations in breast cancer patients and investigate their correlation with certain clinicopathological characteristics. We conducted a mutational investigation of the PIK3CA gene using next-generation sequencing (NGS) in a sample of 100 cases of primary breast cancer. We investigated the associations between PIK3CA mutations and clinicopathological characteristics. Our analysis revealed a mutation rate of 45% in the PIK3CA gene. The mutation frequencies for the three hotspot sites were 33.3% for E545K in exon 10, 26.7% for H1047R in exon 20, and 6.7% for E542K in exon 10. Of the 45 individuals with tumors carrying the PIK3CA mutation, 41 (91.2%) had only one mutation, while 4 (8.8%) had two. Pathogenic PIK3CA mutations were significantly correlated with tumor size ( p = 0.015) and tumor location ( p = 0.017). Our study results demonstrated a significant association between tumor size, location, and presence of the PIK3CA mutation. We must validate these data in larger sample sizes.https://www.termedia.pl/Association-of-PIK3CA-somatic-mutations-with-clinicopathological-parameters-in-breast-cancer,55,55290,1,1.htmlbreast cancer pik3ca mutations hotspot mutations clinicopatholo­gical parameters
spellingShingle Gizem Teoman
Zeynep Turkmen Usta
Zeynep Sagnak Yilmaz
Sevdegul Aydin Mungan
Ismail Saygin
Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
Polish Journal of Pathology
breast cancer
pik3ca
mutations
hotspot mutations
clinicopatholo­gical parameters
title Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
title_full Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
title_fullStr Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
title_full_unstemmed Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
title_short Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
title_sort association of pik3ca somatic mutations with clinicopathological parameters in breast cancer
topic breast cancer
pik3ca
mutations
hotspot mutations
clinicopatholo­gical parameters
url https://www.termedia.pl/Association-of-PIK3CA-somatic-mutations-with-clinicopathological-parameters-in-breast-cancer,55,55290,1,1.html
work_keys_str_mv AT gizemteoman associationofpik3casomaticmutationswithclinicopathologicalparametersinbreastcancer
AT zeynepturkmenusta associationofpik3casomaticmutationswithclinicopathologicalparametersinbreastcancer
AT zeynepsagnakyilmaz associationofpik3casomaticmutationswithclinicopathologicalparametersinbreastcancer
AT sevdegulaydinmungan associationofpik3casomaticmutationswithclinicopathologicalparametersinbreastcancer
AT ismailsaygin associationofpik3casomaticmutationswithclinicopathologicalparametersinbreastcancer